Skip to content

Clinical trials

Lung Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: United States Clear all

403 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20027
200312
200412
200514
20069
20075
20089
200917
20106
20118
201211
201316
201422
201514
201617
201719
201821
201920
202023
202125
202219
202323
202420
202517
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed233
Recruiting57
Terminated49
Active, not recruiting24
Withdrawn19
Unknown status12
Enrolling by invitation5
Not yet recruiting2
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca26
National Heart, Lung, and Blood Institute (NHLBI)10
Johns Hopkins University8
Weill Medical College of Cornell University8
Columbia University7
NYU Langone Health7
Novartis Pharmaceuticals7
University of Pittsburgh7
VA Office of Research and Development7
Eli Lilly and Company6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases403
Respiratory Tract Diseases100
Pulmonary Disease, Chronic Obstructive62
Asthma61
Lung Neoplasms56
Neoplasms42
Lung Diseases, Obstructive37
Carcinoma, Non-Small-Cell Lung33
Thoracic Neoplasms31
Bronchial Diseases30

Trials

Showing 1 to 25 of 403. Each trial links to its page on Pharma Observatory.

303 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.